JUVENILE XANTHOGRANULOMA, NEUROFIBROMATOSIS, AND JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - WORLD STATISTICAL-ANALYSIS

被引:160
作者
ZVULUNOV, A
BARAK, Y
METZKER, A
机构
[1] CHILDRENS MED CTR ISRAEL, DERMATOL UNIT, PETAH TIQWA, ISRAEL
[2] TEL AVIV UNIV, SACKLER SCH MED, IL-69978 TEL AVIV, ISRAEL
[3] HEBREW UNIV JERUSALEM, HADASSAH MED SCH, IL-91010 JERUSALEM, ISRAEL
[4] KAPLAN HOSP, DEPT PEDIAT A, IL-76100 REHOVOT, ISRAEL
关键词
D O I
10.1001/archderm.131.8.904
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Design: The concurrent finding of neurofibromatosis type 1 (NF), juvenile chronic myelogenous leukemia (JCML), and juvenile xanthogranuloma (JXG) has been repeatedly reported. Juvenile chronic myelogenous leukemia has been found more frequently in patients with NF and may present with various cutaneous manifestations, including JXG. To our knowledge, the relationship among these three entities has never been explored. The purpose of the present study is to explore this relationship by using a systematic review of the literature. We present five demonstrative cases of various associations among NF, JCML, and JXG. Results: A family history of NF was found in 85% to 95% of children with NF and JCML (with or without JXG), as compared with that found in 47% of children with NF and JXG. The observed frequency of the triple association is 30-fold to 40-fold higher than that expected. It is estimated that children with NF and JXG have a 20-fold to 32-fold higher risk for JCML than do patients with NF who do not have JXG. Conclusions: A concomitant finding of JCML and JXG in children with NF represents a true association, rather than a coincidence. A finding of JXG in an infant with NF should alert a physician to a possible development of JCML.
引用
收藏
页码:904 / 908
页数:5
相关论文
共 72 条
[1]   JUVENILE XANTHOGRANULOMA AND NEUROFIBROMATOSIS [J].
ACKERMAN, CD ;
COHEN, BA .
PEDIATRIC DERMATOLOGY, 1991, 8 (04) :339-340
[2]  
Arakawa S, 1979, Rinsho Ketsueki, V20, P519
[3]  
BADLER JL, 1978, J PEDIATR, V92, P925
[4]  
BARAK Y, 1990, Harefuah, V118, P62
[5]  
BERNHEIM M, 1956, Pediatrie, V11, P399
[6]   JUVENILE CHRONIC MYELOGENOUS LEUKEMIA AND DERMAL HISTIOCYTOSIS - IN VON RECKLINGHAUSENS DISEASE [J].
BESTAK, M ;
MILLER, DR ;
MOURADIAN, JS .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1979, 133 (08) :831-833
[7]  
CASTROMALASPINA H, 1984, CANCER, V54, P675, DOI 10.1002/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO
[8]  
2-Q
[9]   THE VALUE OF INTENSIVE COMBINATION CHEMOTHERAPY FOR JUVENILE CHRONIC MYELOGENOUS LEUKEMIA [J].
CHAN, HSL ;
ESTROV, Z ;
WEITZMAN, SS ;
FREEDMAN, MH .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1960-1967
[10]  
CHAN LC, 1991, LEUKEMIA, V5, P1113